{"id":"https://openalex.org/W4213020187","doi":"https://doi.org/10.1093/ofid/ofy210.497","title":"488. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridium difficile Infection in Critically Ill Patients","display_name":"488. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridium difficile Infection in Critically Ill Patients","publication_year":2018,"publication_date":"2018-11-01","ids":{"openalex":"https://openalex.org/W4213020187","doi":"https://doi.org/10.1093/ofid/ofy210.497"},"language":"en","primary_location":{"id":"doi:10.1093/ofid/ofy210.497","doi":"https://doi.org/10.1093/ofid/ofy210.497","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.497","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/ofid/ofy210.497","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044691547","display_name":"Ana D Vega","orcid":"https://orcid.org/0000-0003-1974-4547","observed_orcids":["https://orcid.org/0000-0003-1974-4547"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ana Vega","raw_affiliation_strings":["Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103873181","display_name":"Teri L. Hopkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210144081","display_name":"South Texas Veterans Health Care System","ror":"https://ror.org/03n2ay196","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210144023","https://openalex.org/I4210144081"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teri Hopkins","raw_affiliation_strings":["South Texas Veterans Health Care System (STVHCS), San Antonio, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South Texas Veterans Health Care System (STVHCS), San Antonio, Texas","institution_ids":["https://openalex.org/I4210144081"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036700991","display_name":"Emily L. Heil","orcid":"https://orcid.org/0000-0002-6644-6684","observed_orcids":["https://orcid.org/0000-0002-6644-6684"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emily Heil","raw_affiliation_strings":["Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101520312","display_name":"Jennifer Kristie Johnson","orcid":"https://orcid.org/0000-0001-8872-2291","observed_orcids":["https://orcid.org/0000-0001-8872-2291"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Johnson","raw_affiliation_strings":["University of Maryland, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Maryland, Baltimore, Maryland","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005654050","display_name":"Surbhi Leekha","orcid":"https://orcid.org/0000-0002-4565-6439","observed_orcids":["https://orcid.org/0000-0002-4565-6439"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Surbhi Leekha","raw_affiliation_strings":["Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5073613133","display_name":"Kimberly C. Claeys","orcid":"https://orcid.org/0000-0001-6895-604X","observed_orcids":["https://orcid.org/0000-0001-6895-604X"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly Claeys","raw_affiliation_strings":["Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland","institution_ids":["https://openalex.org/I126744593"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4053,"currency":"USD","value_usd":4053},"apc_paid":{"value":4053,"currency":"USD","value_usd":4053},"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"suppl_1","first_page":"S181","last_page":"S181"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11288","display_name":"Clostridium difficile and Clostridium perfringens research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10218","display_name":"Sepsis Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12167","display_name":"Bacterial Identification and Susceptibility Testing","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clostridium-difficile-infection","display_name":"Clostridium difficile infection","score":0.9980000257492065},{"id":"https://openalex.org/keywords/oral-vancomycin","display_name":"oral vancomycin","score":0.9079999923706055},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.859000027179718},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.7649999856948853},{"id":"https://openalex.org/keywords/critically-ill-patients","display_name":"critically ill patients","score":0.9340000152587891},{"id":"https://openalex.org/keywords/intensive-care-unit","display_name":"intensive care unit","score":0.9520000219345093},{"id":"https://openalex.org/keywords/30-day-mortality","display_name":"30-day mortality","score":0.9860000014305115},{"id":"https://openalex.org/keywords/apache-ii","display_name":"APACHE II score","score":0.9940000176429749},{"id":"https://openalex.org/keywords/nucleic-acid-amplification-testing","display_name":"nucleic acid amplification tests","score":0.7540000081062317},{"id":"https://openalex.org/keywords/white-blood-cell-count","display_name":"white blood cell count","score":0.7229999899864197},{"id":"https://openalex.org/keywords/antibiotic-dosing","display_name":"antibiotic dosing","score":0.4440000057220459},{"id":"https://openalex.org/keywords/risk-factors-for-mortality","display_name":"mortality risk factors","score":0.48100000619888306},{"id":"https://openalex.org/keywords/toxic-megacolon","display_name":"toxic megacolon","score":0.5339999794960022}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9504795074462891},{"id":"https://openalex.org/C2777396551","wikidata":"https://www.wikidata.org/wiki/Q169569","display_name":"Metronidazole","level":3,"score":0.6985493898391724},{"id":"https://openalex.org/C2994496256","wikidata":"https://www.wikidata.org/wiki/Q27031090","display_name":"Clostridium difficile","level":3,"score":0.6893409490585327},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6732386350631714},{"id":"https://openalex.org/C2778980435","wikidata":"https://www.wikidata.org/wiki/Q424027","display_name":"Vancomycin","level":4,"score":0.5548831820487976},{"id":"https://openalex.org/C2776376669","wikidata":"https://www.wikidata.org/wiki/Q5094647","display_name":"Intensive care unit","level":2,"score":0.5120406746864319},{"id":"https://openalex.org/C2780347030","wikidata":"https://www.wikidata.org/wiki/Q344843","display_name":"APACHE II","level":3,"score":0.46560603380203247},{"id":"https://openalex.org/C2776611563","wikidata":"https://www.wikidata.org/wiki/Q588321","display_name":"Toxic megacolon","level":4,"score":0.46093645691871643},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.41137850284576416},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.17584466934204102},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0788739025592804},{"id":"https://openalex.org/C523546767","wikidata":"https://www.wikidata.org/wiki/Q10876","display_name":"Bacteria","level":2,"score":0.0},{"id":"https://openalex.org/C2779489039","wikidata":"https://www.wikidata.org/wiki/Q188121","display_name":"Staphylococcus aureus","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C2780479503","wikidata":"https://www.wikidata.org/wiki/Q1477","display_name":"Ulcerative colitis","level":3,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/ofid/ofy210.497","doi":"https://doi.org/10.1093/ofid/ofy210.497","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.497","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5238672","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6254308","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6254308","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6254308","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Open Forum Infect Dis","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/ofid/ofy210.497","doi":"https://doi.org/10.1093/ofid/ofy210.497","is_oa":true,"landing_page_url":"https://doi.org/10.1093/ofid/ofy210.497","pdf_url":null,"source":{"id":"https://openalex.org/S2735126445","display_name":"Open Forum Infectious Diseases","issn_l":"2328-8957","issn":["2328-8957"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Open Forum Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8799999952316284}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W201859799","https://openalex.org/W1896659599","https://openalex.org/W2315158665","https://openalex.org/W2057942785","https://openalex.org/W2413136907","https://openalex.org/W2147086626","https://openalex.org/W2167016769","https://openalex.org/W2982006247","https://openalex.org/W2323391087","https://openalex.org/W2311470226"],"abstract_inverted_index":{"There":[0,283,340],"remains":[1,341],"a":[2,54,116,156,210,232,299,342],"paucity":[3],"of":[4,9,60,70,74,82,102,237,289,301,326],"data":[5,322],"regarding":[6],"optimal":[7],"treatment":[8],"patients":[10,68,90,104,159,186,203,302,336],"with":[11,57,91,95,115,181,193,272,337],"severe":[12,92,338],"Clostridium":[13],"difficile":[14,119],"infection":[15],"(CDI)":[16],"in":[17,46,88,204,250,256,287,329,348],"the":[18,27,80,205,251,257,267,324],"intensive":[19],"care":[20],"unit":[21],"(ICU).":[22],"Based":[23],"on":[24,85,294],"expert":[25],"opinion,":[26],"2018":[28,114],"SHEA-IDSA":[29],"CDI":[30,48],"Clinical":[31],"Practice":[32],"Guidelines":[33],"recommend":[34],"combination":[35,58,83,191,252],"therapy":[36,59,84,192],"(oral":[37],"vancomycin":[38],"[PO":[39],"VAN]":[40],"plus":[41,63],"intravenous":[42],"metronidazole":[43],"[IV":[44],"MDZ])":[45],"fulminant":[47],"only.":[49],"A":[50],"2015":[51],"study":[52,76],"suggested":[53],"mortality":[55,247,274,311],"benefit":[56],"PO":[61,96,128,238,332],"VAN":[62,97,129,239,333],"IV":[64,194,206,291,327],"MDZ":[65,207,292,328],"for":[66,127,132,334,344],"ICU":[67,89,108,335],"regardless":[69],"severity.":[71],"The":[72,147],"objective":[73],"this":[75,349],"was":[77,150,174,248,266,284],"to":[78,106,176,230,331],"determine":[79],"impact":[81],"clinical":[86,178],"outcomes":[87],"CDI,":[93],"compared":[94],"monotherapy.":[98],"Single-center,":[99],"retrospective,":[100],"cohort":[101],"adult":[103],"admitted":[105],"an":[107,125],"between":[109],"April":[110,113],"2016":[111],"and":[112,124,165,226],"positive":[117],"C.":[118],"nucleic":[120],"acid":[121],"amplification":[122],"test":[123],"order":[126],"were":[130,135,160,187,198,227],"screened":[131],"inclusion.":[133],"Patients":[134],"excluded":[136],"if":[137],"they":[138],"had":[139,209],"life-threatening":[140],"intra-abdominal":[141],"complications,":[142],"including":[143],"toxic":[144],"megacolon/emergent":[145],"colectomy.":[146],"primary":[148],"outcome":[149],"30-day":[151,273],"in-hospital":[152],"all-cause":[153],"mortality.":[154,182],"In":[155,298],"subgroup":[157,300],"analysis,":[158],"matched":[161,303],"using":[162],"Acute":[163],"Physiology":[164],"Chronic":[166],"Health":[167],"Evaluation":[168],"(APACHE)":[169],"II":[170,264,296,306],"scores.":[171],"Logistic":[172],"regression":[173],"conducted":[175],"identify":[177],"variables":[179],"associated":[180,271],"One":[183],"hundred":[184],"one":[185],"included;":[188],"47":[189],"received":[190],"MDZ.":[195],"Baseline":[196],"characteristics":[197],"similar":[199],"across":[200],"groups,":[201],"except":[202],"group":[208,253],"higher":[211,233],"median":[212],"white":[213],"blood":[214],"cell":[215],"(WBC)":[216],"count":[217],"at":[218],"diagnosis":[219],"(18.4":[220],"vs.":[221,241,254,316],"13.9,":[222],"P":[223,243,318],"=":[224,261,276,309,319],"0.023)":[225],"more":[228],"likely":[229],"receive":[231],"dose":[234],"(500":[235],"mg)":[236],"(36.2%":[240],"7.4%,":[242],"<":[244],"0.0001).":[245],"Thirty-day":[246],"14.9%":[249],"7.4%":[255],"monotherapy":[258],"group,":[259],"(P":[260],"0.338).":[262],"APACHE":[263,295,305],"Score":[265],"only":[268],"variable":[269],"independently":[270],"(OR":[275],"1.13,":[277],"95%":[278],"CI":[279],"1.03":[280],"\u2013":[281],"1.24).":[282],"no":[285],"difference":[286],"probability":[288],"receiving":[290],"based":[293],"score.":[297],"by":[304,346],"score":[307],"(n":[308],"76),":[310],"remained":[312],"nonsignificantly":[313],"different":[314],"(15.8%":[315],"9.7%,":[317],"0.480).":[320],"Our":[321],"question":[323],"utility":[325],"addition":[330],"CDI.":[339],"possibility":[343],"confounding":[345],"indication":[347],"retrospective":[350],"analysis.":[351],"E.":[352],"Heil,":[353],"ALK-Abell\u00f3:":[354],"Grant":[355],"Investigator,":[356],"Research":[357],"grant.":[358],"K.":[359],"Claeys,":[360],"Nabriva:":[361],"Scientific":[362,367],"Advisor,":[363,368],"Consulting":[364,369],"fee.":[365,370],"Melinta:":[366]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2025-10-10T00:00:00"}